Print
07 February 2017
Robert Zirkelbach / PhRMA
Today, as part of our new advertising and public affairs initiative, GOBOLDLY, we are excited to announce the premier of our newest TV advertisement, Cells, which highlights innovative immunotherapy treatments by America’s biopharmaceutical companies.
Cells is a rarely seen, front row seat to the destruction of a cancer cell by the body’s own immune system stimulated by new advancements in immuno-oncology. With this new style of targeted treatment, scientists have begun replacing chemotherapy with immunotherapy, dramatically improving the lives of patients and bringing us closer to the goal of one day rendering cancer obsolete.
Learn more about how America’s biopharmaceutical companies are working tirelessly to find new ways to fight cancer at GoBoldly.com and Innovation.org.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.